Our Model
At Formation Bio we acquire promising clinical-stage drug candidates and develop them in house. We bring together best in class talent from the pharma and technology industries, combining sophisticated development strategy with proprietary technology and AI capabilities that can power hyper-efficient drug development.
Partners
Pharma
Biotech
Universities
Formation Bio Drug development Platform
Bespoke Exit Pathways
How We Operate
Acquire drug assets
Acquire clinical-stage drugs in a variety of therapeutic areas
Develop drugs in-house
Leverage development engine to uniquely develop drugs faster and maximize value
Realize value inflection points
Realize increased value through bespoke exit and development pathways
Drug Development Platform
Formation Bio is an end-to-end drug developer that leverages its proprietary tech-driven platform to develop drugs faster and more efficiently, unlocking greater value per program and accelerating access to new treatments for patients.
- 01
Research and development
Our teams and advisors have worked on 45+ approved drugs, and bring deep cross-functional expertise across all elements of drug development.
- 02
Clinical operations
Our trials are run in-house by our top tier clinical operations functions, including patient recruitment, site management, and study monitoring.
- 03
Technology
All of our platforms are supported by our integrated tech platform, including patient intelligence, data surveillance, and a universal data layer.
Advantages of our Model
Formation Bio’s end-to-end tech-driven drug development platform optimizes all aspects of the drug development lifecycle, with core competitive advantages across: